首页> 外文OA文献 >20P Synergistic inhibition of growth of KRAS-driven NSCLC by MEK inhibitor in combination with a novel multi-target tyrosine kinase inhibitor anlotinib via IGFBP-mediated signaling

【2h】

20P Synergistic inhibition of growth of KRAS-driven NSCLC by MEK inhibitor in combination with a novel multi-target tyrosine kinase inhibitor anlotinib via IGFBP-mediated signaling

机译：MEK抑制剂与新型多靶酪氨酸激酶抑制剂Anlotinib通过IGFBP介导的信号传导组合的20P协同抑制KRAS驱动的NSCLC的生长

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M. Hu; J. Lu; B. Han;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells [J] . Mi Zhang, Haitian Quan, Li Fu, Thoracic cancer. . 2021,第8期

机译：第三代EGFR抑制剂HS-10296与Famitinib组合，一种多目标酪氨酸激酶抑制剂，通过增强EGFR-突变体非小细胞肺癌细胞中的下游信号抑制来施加协同抗肿瘤效果
2. 606 POSTER Augmented growth inhibition of human NSCLC cells resistant to EGFR-tyrosine kinase inhibitor (TKl) by a combination of dual TKl of EGFR/VEGFR2 (AEE788) and mTOR inhibitor (RAD001) [J] . K.Soejima, I.Nakachi, K.Naoki, European Journal of Cancer Supplements . 2006,第12期

机译：606 POSTER通过双重TK1的EGFR / VEGFR2（AEE788）和mTOR抑制剂（RAD001）的组合增强了对EGFR-酪氨酸激酶抑制剂（TK1）耐药的人NSCLC细胞的生长抑制
3. Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing tyrosine kinase inhibitors in small cell lung cancer cells: Implication of c-Src and its inhibitor [J] . Yasuto Ueda, Tadashi Igishi, Kiyoshi Hashimoto, International journal of oncology . 2009,第3期

机译：氨柔比星和抑制Akt的酪氨酸激酶抑制剂在小细胞肺癌细胞中协同抑制细胞生长：c-Src及其抑制剂的意义
4. Combination effects of repetitive pulsed magnetic stimulation and tyrosine kinase inhibitor imatinib for chronic myeloid leukemia cell line TCC-S [C] . S. Yamaguchi, M. Sekino, Y. Sato, Intermag Conference . 2006

机译：重复脉冲磁刺激和酪氨酸激酶抑制剂慢性髓性白血病细胞系TCC-S的组合效应
5. The multi-targeted receptor tyrosine kinase inhibitor, linifanib (ABT-869), induces apoptosis and inhibits proliferation of leukemia cells through phosphoinositide-3 kinase (PI3K)/AKT-dependent signaling pathways. [D] . Hernandez, Jenny Elizabeth. 2010

机译：多靶点受体酪氨酸激酶抑制剂利尼法尼（ABT-869）通过磷酸肌醇3激酶（PI3K）/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
6. Third‐generation EGFR inhibitor HS‐10296 in combination with famitinib a multi‐targeted tyrosine kinase inhibitor exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR‐mutant non‐small cell lung cancer cells [O] . Mi Zhang, Haitian Quan, Li Fu, 2021

机译：第三代EGFR抑制剂HS-10296与Famitinib组合一种多靶向酪氨酸激酶抑制剂通过增强EGFR-突变体非小细胞肺癌细胞中的下游信号传导来施加协同抗肿瘤效果
7. Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: Implication of EGFR tyrosine kinase inhibitors [O] . SHIZUKA ITO, TADASHI IGISHI, MIYAKO TAKATA, 2014

机译：通过K-Ras突变巢肺腺癌细胞中的氨霉素和Akt抑制剂的组合的协同细胞生长抑制：EGFR酪氨酸激酶抑制剂的含义

20P Synergistic inhibition of growth of KRAS-driven NSCLC by MEK inhibitor in combination with a novel multi-target tyrosine kinase inhibitor anlotinib via IGFBP-mediated signaling

著录项

引文网络

相似文献

相关主题

期刊订阅